News
Wegovy, Novo Nordisk and Liver Disease
Digest more
With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...
Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
The label expansion could help Novo Nordisk “help shift the momentum” for Wegovy, after a difficult start to 2025, according ...
The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...
Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...
Hosted on MSN6h
How to switch from Mounjaro to Wegovy WITHOUT risking side effects or weight gain, reveals top GP
His statement comes as CheqUp, one of the UK's largest providers of weight-loss treatments, reports sales of rival treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback